Best Practices in the Management of Infectious Complications for Patients With Cancer
Presented by James S. Lewis II, PharmD, FIDSA
Oregon Health & Science University, Portland, Oregon
Presenter’s disclosures of potential conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2017;8:291–295 |
© 2017 Harborside Press®
As antibiotic resistant bacteria are becoming ubiquitous, managing infection becomes more complex. Optimizing preventive measures, early diagnosis, and management of infection is of the highest priority in cancer care.
For access to the full length article, please sign in